WallStSmart
PFSA

Profusa, Inc. Common Stock

NASDAQ: PFSA · HEALTHCARE · MEDICAL DEVICES

$0.48
-8.09% today

Updated 2026-06-04

Market cap
$1.28M
P/E ratio
P/S ratio
104.68x
EPS (TTM)
$-15.36
Dividend yield
52W range
$0 – $413
Volume
6.0M

Profusa, Inc. Common Stock (PFSA) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item20212022202320242025
Total assets$11.36M$1.03M$1.89M$3.07M$3.77M
Cash & equivalents$856000.00$78000.00$142000.00$191000.00$1.78M
Current assets$958000.00$160000.00$333000.00$260000.00$3.76M
Total liabilities$95.02M$100.80M$111.89M$122.28M$30.43M
Current liabilities$21.61M$35.65M$46.74M$57.13M$22.26M
Long-term debt$1.19M$7.88M
Shareholder equity$-83.66M$-99.77M$-110.00M$-119.20M$-26.66M
Retained earnings$-85.23M$-105.45M$-115.73M$-124.96M$-160.78M
Accounts receivable$38000.00$0.00$45000.00
Inventory
Goodwill

Frequently asked questions

How much free cash flow does PFSA generate?

PFSA produced $-16.26M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is PFSA's balance sheet healthy?

PFSA holds $1.78M in cash and equivalents against $7.88M in long-term debt, on $-26.66M of shareholder equity. That debt is best read against the cash flow the business throws off each year.